Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-30 Purchase |
2024-02-01 4:47 pm |
ArriVent Biopharma Inc. | AVBP | HILLHOUSE INVESTMENT MANAGEMENT LTD. HHLR ADVISORS LTD. 10% Owner |
555,555 | $18 | $9,999,990 | 4,484,672 (Indirect) |
View |
| 2024-01-30 Purchase |
2024-01-31 4:12 pm |
ArriVent Biopharma Inc. | AVBP | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors IV Ltd OrbiMed Asia GP IV L.P. Director 10% Owner |
444,444 | $18 | $7,999,992 | 1,513,664 (Indirect) |
View |
| 2024-01-30 Purchase |
2024-01-31 4:11 pm |
ArriVent Biopharma Inc. | AVBP | GORDON CARL L Director 10% Owner |
444,444 | $18 | $7,999,992 | 1,513,664 (Indirect) |
View |
| 2024-01-30 Purchase |
2024-01-31 4:10 pm |
ArriVent Biopharma Inc. | AVBP | HEALY JAMES Director |
444,444 | $18 | $7,999,992 | 1,696,752 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-03 Option Award |
2025-02-14 4:27 pm |
N/A 2035-02-03 |
ArriVent BioPharma Inc. | AVBP | Yao Zhengbin President and CEO |
380,000 | $0 | 380,000 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-14 4:26 pm |
N/A 2035-02-03 |
ArriVent BioPharma Inc. | AVBP | Lutzker Stuart President of R&D |
120,000 | $0 | 120,000 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-14 4:25 pm |
N/A 2035-02-03 |
ArriVent BioPharma Inc. | AVBP | LaChapelle Robin Chief Operating Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-14 4:24 pm |
N/A 2035-02-03 |
ArriVent BioPharma Inc. | AVBP | Kung Winston Chief Financial Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-14 4:23 pm |
N/A 2035-02-03 |
ArriVent BioPharma Inc. | AVBP | Kastenmayer James Paul General Counsel |
102,000 | $0 | 102,000 (Direct) |
View |
| 2024-09-19 Exercise |
2024-09-23 6:14 pm |
N/A N/A |
ArriVent BioPharma Inc. | AVBP | LaChapelle Robin Chief Operating Officer |
12,364 | $3.65 | 634,966 (Direct) |
View |
| 2024-09-19 Exercise |
2024-09-23 6:14 pm |
N/A N/A |
ArriVent BioPharma Inc. | AVBP | LaChapelle Robin Chief Operating Officer |
2,700 | $6.24 | 634,966 (Direct) |
View |
| 2024-09-19 Exercise |
2024-09-23 6:14 pm |
N/A N/A |
ArriVent BioPharma Inc. | AVBP | LaChapelle Robin Chief Operating Officer |
12,502 | $2.28 | 634,966 (Direct) |
View |
| 2024-09-19 Exercise |
2024-09-23 6:14 pm |
N/A 2031-09-07 |
ArriVent BioPharma Inc. | AVBP | LaChapelle Robin Chief Operating Officer |
27,566 | $0 | 634,966 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 5:30 pm |
N/A 2034-05-15 |
ArriVent BioPharma Inc. | AVBP | Hohneker John Director |
29,550 | $0 | 29,550 (Direct) |
View |
| 2024-04-22 Option Award |
2024-04-23 4:06 pm |
N/A 2034-04-21 |
ArriVent BioPharma Inc. | AVBP | Peterson Kristine Director |
28,587 | $0 | 28,587 (Direct) |
View |
| 2024-01-30 Conversion |
2024-02-01 4:47 pm |
N/A N/A |
ArriVent Biopharma Inc. | AVBP | HILLHOUSE INVESTMENT MANAGEMENT LTD. HHLR ADVISORS LTD. 10% Owner |
63,691,020 | $0 | 4,484,672 (Indirect) |
View |
| 2024-01-30 Conversion |
2024-01-31 4:12 pm |
N/A N/A |
ArriVent Biopharma Inc. | AVBP | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors IV Ltd OrbiMed Asia GP IV L.P. Director 10% Owner |
2,582,884 | $0 | 1,513,664 (Indirect) |
View |
| 2024-01-30 Conversion |
2024-01-31 4:11 pm |
N/A N/A |
ArriVent Biopharma Inc. | AVBP | GORDON CARL L Director 10% Owner |
2,582,884 | $0 | 1,513,664 (Indirect) |
View |
| 2024-01-30 Conversion |
2024-01-31 4:10 pm |
N/A N/A |
ArriVent Biopharma Inc. | AVBP | HEALY JAMES Director |
1,252,308 | $0 | 1,696,752 (Indirect) |
View |
| 2024-01-25 Option Award |
2024-01-29 4:16 pm |
N/A 2034-01-24 |
ArriVent Biopharma Inc. | AVBP | Nolet Chris Director |
17,884 | $0 | 17,884 (Direct) |
View |
| 2024-01-25 Option Award |
2024-01-29 4:15 pm |
N/A 2034-01-24 |
ArriVent Biopharma Inc. | AVBP | Jallal Bahija Director |
17,884 | $0 | 17,884 (Direct) |
View |
Ownership |
2024-01-25 9:01 pm |
N/A N/A |
ArriVent Biopharma Inc. | AVBP | HILLHOUSE INVESTMENT MANAGEMENT LTD. 10% Owner |
0 | $0 | 3,929,117 (Indirect) |
View |
Ownership |
2024-01-25 8:40 pm |
N/A N/A |
ArriVent Biopharma Inc. | AVBP | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors IV Ltd OrbiMed Asia GP IV L.P. Director 10% Owner |
0 | $0 | 2,582,884 (Indirect) |
View |
Ownership |
2024-01-25 8:39 pm |
N/A N/A |
ArriVent Biopharma Inc. | AVBP | Yao Zhengbin President and CEO |
0 | $0 | 1,369,489 (Indirect) |
View |
Ownership |
2024-01-25 8:39 pm |
N/A 2033-09-07 |
ArriVent Biopharma Inc. | AVBP | Nolet Chris Director |
0 | $0 | 16,436 (Direct) |
View |
Ownership |
2024-01-25 8:39 pm |
N/A N/A |
ArriVent Biopharma Inc. | AVBP | Lutzker Stuart President of R&D |
0 | $0 | 373,251 (Direct) |
View |
Ownership |
2024-01-25 8:38 pm |
N/A N/A |
ArriVent Biopharma Inc. | AVBP | LaChapelle Robin Chief Operating Officer |
0 | $0 | 661,636 (Direct) |
View |
Ownership |
2024-01-25 8:38 pm |
N/A 2034-01-03 |
ArriVent Biopharma Inc. | AVBP | Kung Winston Chief Financial Officer |
0 | $0 | 197,238 (Direct) |
View |
Ownership |
2024-01-25 8:38 pm |
N/A N/A |
ArriVent Biopharma Inc. | AVBP | Kastenmayer James Paul General Counsel |
0 | $0 | 106,004 (Direct) |
View |
Ownership |
2024-01-25 8:37 pm |
N/A N/A |
ArriVent Biopharma Inc. | AVBP | HEALY JAMES Director |
0 | $0 | 1,252,308 (Indirect) |
View |
Ownership |
2024-01-25 8:36 pm |
N/A N/A |
ArriVent Biopharma Inc. | AVBP | GORDON CARL L Director 10% Owner |
0 | $0 | 2,582,884 (Indirect) |
View |
Ownership |
2024-01-25 8:36 pm |
N/A 2032-01-31 |
ArriVent Biopharma Inc. | AVBP | Jallal Bahija Director |
0 | $0 | 19,723 (Direct) |
View |